TRIANgLE study (JCOG1510): A phase III study of tri-modality combination therapy with induction docetaxel (DOC), cisplatin (CDDP), 5-fluorouracil (FU) (DCF) vs definitive chemoradiotherapy (dCRT) for locally advanced unresectable squamous cell carcinoma (SCC) of the thoracic esophagus

H. Daiko; H. Hara; H. Ogawa; K. Hori; J. Mizusawa; S. Ozawa; M. Takagi; M. Tanaka; H. Baba; Y. Shirakawa; M. Tsuda; S. Nakagawa; H. Takeuchi; T. Abe; Y. Ito; T. Kojima; T. Kadota; H. Fukuda; K. Kato; Y. Kitagawa

doi:10.1093/annonc/mdy282.162

TRIANgLE study (JCOG1510): A phase III study of tri-modality combination therapy with induction docetaxel (DOC), cisplatin (CDDP), 5-fluorouracil (FU) (DCF) vs definitive chemoradiotherapy (dCRT) for locally advanced unresectable squamous cell carcinoma (SCC) of the thoracic esophagus

H. Daiko, H. Hara, H. Ogawa, K. Hori, J. Mizusawa, S. Ozawa, M. Takagi, M. Tanaka, H. Baba, Y. Shirakawa, M. Tsuda, S. Nakagawa, H. Takeuchi, T. Abe, Y. Ito, T. Kojima, T. Kadota, H. Fukuda, K. Kato, Y. Kitagawa

外科学(一般・消化器)

研究成果: Article › 査読

本文言語	English
ページ（範囲）	viii266
ジャーナル	Annals of oncology : official journal of the European Society for Medical Oncology
巻	29
DOI	https://doi.org/10.1093/annonc/mdy282.162
出版ステータス	Published - 2018 10月 1

ASJC Scopus subject areas

血液学
腫瘍学

文献へのアクセス

10.1093/annonc/mdy282.162

他のファイルとリンク

引用スタイル

Daiko, H., Hara, H., Ogawa, H., Hori, K., Mizusawa, J., Ozawa, S., Takagi, M., Tanaka, M., Baba, H., Shirakawa, Y., Tsuda, M., Nakagawa, S., Takeuchi, H., Abe, T., Ito, Y., Kojima, T., Kadota, T., Fukuda, H., Kato, K., & Kitagawa, Y. (2018). TRIANgLE study (JCOG1510): A phase III study of tri-modality combination therapy with induction docetaxel (DOC), cisplatin (CDDP), 5-fluorouracil (FU) (DCF) vs definitive chemoradiotherapy (dCRT) for locally advanced unresectable squamous cell carcinoma (SCC) of the thoracic esophagus. Annals of oncology : official journal of the European Society for Medical Oncology, 29, viii266. https://doi.org/10.1093/annonc/mdy282.162

TRIANgLE study (JCOG1510) : A phase III study of tri-modality combination therapy with induction docetaxel (DOC), cisplatin (CDDP), 5-fluorouracil (FU) (DCF) vs definitive chemoradiotherapy (dCRT) for locally advanced unresectable squamous cell carcinoma (SCC) of the thoracic esophagus. / Daiko, H.; Hara, H.; Ogawa, H. その他.

In: Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, 01.10.2018, p. viii266.

研究成果: Article › 査読

Daiko, H, Hara, H, Ogawa, H, Hori, K, Mizusawa, J, Ozawa, S, Takagi, M, Tanaka, M, Baba, H, Shirakawa, Y, Tsuda, M, Nakagawa, S, Takeuchi, H, Abe, T, Ito, Y, Kojima, T, Kadota, T, Fukuda, H, Kato, K & Kitagawa, Y 2018, 'TRIANgLE study (JCOG1510): A phase III study of tri-modality combination therapy with induction docetaxel (DOC), cisplatin (CDDP), 5-fluorouracil (FU) (DCF) vs definitive chemoradiotherapy (dCRT) for locally advanced unresectable squamous cell carcinoma (SCC) of the thoracic esophagus', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 29, pp. viii266. https://doi.org/10.1093/annonc/mdy282.162

Daiko H, Hara H, Ogawa H, Hori K, Mizusawa J, Ozawa S その他. TRIANgLE study (JCOG1510): A phase III study of tri-modality combination therapy with induction docetaxel (DOC), cisplatin (CDDP), 5-fluorouracil (FU) (DCF) vs definitive chemoradiotherapy (dCRT) for locally advanced unresectable squamous cell carcinoma (SCC) of the thoracic esophagus. Annals of oncology : official journal of the European Society for Medical Oncology. 2018 10月 1;29:viii266. doi: 10.1093/annonc/mdy282.162

Daiko, H. ; Hara, H. ; Ogawa, H. その他. / TRIANgLE study (JCOG1510) : A phase III study of tri-modality combination therapy with induction docetaxel (DOC), cisplatin (CDDP), 5-fluorouracil (FU) (DCF) vs definitive chemoradiotherapy (dCRT) for locally advanced unresectable squamous cell carcinoma (SCC) of the thoracic esophagus. In: Annals of oncology : official journal of the European Society for Medical Oncology. 2018 ; Vol. 29. pp. viii266.

@article{4e4de3bd0c8f40f689dba0f4255eb35e,

title = "TRIANgLE study (JCOG1510): A phase III study of tri-modality combination therapy with induction docetaxel (DOC), cisplatin (CDDP), 5-fluorouracil (FU) (DCF) vs definitive chemoradiotherapy (dCRT) for locally advanced unresectable squamous cell carcinoma (SCC) of the thoracic esophagus",

author = "H. Daiko and H. Hara and H. Ogawa and K. Hori and J. Mizusawa and S. Ozawa and M. Takagi and M. Tanaka and H. Baba and Y. Shirakawa and M. Tsuda and S. Nakagawa and H. Takeuchi and T. Abe and Y. Ito and T. Kojima and T. Kadota and H. Fukuda and K. Kato and Y. Kitagawa",

year = "2018",

month = oct,

day = "1",

doi = "10.1093/annonc/mdy282.162",

language = "English",

volume = "29",

pages = "viii266",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - TRIANgLE study (JCOG1510)

T2 - A phase III study of tri-modality combination therapy with induction docetaxel (DOC), cisplatin (CDDP), 5-fluorouracil (FU) (DCF) vs definitive chemoradiotherapy (dCRT) for locally advanced unresectable squamous cell carcinoma (SCC) of the thoracic esophagus

AU - Daiko, H.

AU - Hara, H.

AU - Ogawa, H.

AU - Hori, K.

AU - Mizusawa, J.

AU - Ozawa, S.

AU - Takagi, M.

AU - Tanaka, M.

AU - Baba, H.

AU - Shirakawa, Y.

AU - Tsuda, M.

AU - Nakagawa, S.

AU - Takeuchi, H.

AU - Abe, T.

AU - Ito, Y.

AU - Kojima, T.

AU - Kadota, T.

AU - Fukuda, H.

AU - Kato, K.

AU - Kitagawa, Y.

PY - 2018/10/1

Y1 - 2018/10/1

UR - http://www.scopus.com/inward/record.url?scp=85081527806&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85081527806&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdy282.162

DO - 10.1093/annonc/mdy282.162

M3 - Article

C2 - 32136607

SN - 0923-7534

VL - 29

SP - viii266

JO - Annals of Oncology

JF - Annals of Oncology

ER -